Department of Health and Human Services December 3, 2021 – Federal Register Recent Federal Regulation Documents

Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS)
Document Number: 2021-26317
Type: Notice
Date: 2021-12-03
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS). This meeting is open to the public.
National Cancer Institute; Amended Notice of Meeting
Document Number: 2021-26273
Type: Notice
Date: 2021-12-03
Agency: Department of Health and Human Services, National Institutes of Health
Proposed Information Collection Activity; ACF-801: Child Care and Development Fund (CCDF) Quarterly Case-Level Report
Document Number: 2021-26272
Type: Notice
Date: 2021-12-03
Agency: Department of Health and Human Services, Administration for Children and Families
The Office of Child Care (OCC), Administration for Children and Families (ACF) is requesting a 3-year extension of the form ACF- 801: CCDF Quarterly Case-Level Report (OMB #0970-0167, expiration 2/28/ 2022). OCC proposes minor changes to the response categories under the following three data elements: Child's gender, ethnicity, and race.
Notice for Public Comment on Administration for Native Americans' Program Policies and Procedures
Document Number: 2021-26271
Type: Notice
Date: 2021-12-03
Agency: Department of Health and Human Services, Administration for Children and Families
Pursuant to Section 814 of the Native American Programs Act of 1974 (NAPA), as amended, the Administration for Native Americans (ANA) is required to provide members of the public an opportunity to comment on proposed changes in interpretive rules and general statements of policy and to give notice of the proposed changes no less than 30 days before such changes become effective.
Request for Nominations on the National Mammography Quality Assurance Advisory Committee
Document Number: 2021-26264
Type: Notice
Date: 2021-12-03
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is requesting that any industry organizations interested in participating in the selection of nonvoting industry representatives to serve on the National Mammography Quality Assurance Advisory Committee in the Center for Devices and Radiological Health notify FDA in writing. FDA is also requesting nominations for nonvoting industry representatives to serve on the National Mammography Quality Assurance Advisory Committee. A nominee may either be self-nominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for current vacancies effective with this notice.
Agency Information Collection Activities; Proposed Collection; Comment Request; Standards for the Growing, Harvesting, Packaging, and Holding of Produce for Human Consumption
Document Number: 2021-26261
Type: Notice
Date: 2021-12-03
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection associated with the standards for the growing, harvesting, packing, and holding of produce for human consumption.
Request for Nominations of Voting Members on a Public Advisory Committee; National Mammography Quality Assurance Advisory Committee
Document Number: 2021-26258
Type: Notice
Date: 2021-12-03
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the National Mammography Quality Assurance Advisory Committee in the Center for Devices and Radiological Health. Nominations will be accepted for current and upcoming vacancies effective February 1, 2022, with this notice. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore, encourages nominations of appropriately qualified candidates from these groups.
Center for Scientific Review; Notice of Closed Meeting
Document Number: 2021-26250
Type: Notice
Date: 2021-12-03
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Aging Notice of Closed Meeting
Document Number: 2021-26249
Type: Notice
Date: 2021-12-03
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Document Number: 2021-26247
Type: Notice
Date: 2021-12-03
Agency: Department of Health and Human Services, National Institutes of Health
Announcement of Solicitation of Written Comments on Proposed Healthy People 2030 Objectives and Request for Information on the Relationship Between Voter Participation and Health
Document Number: 2021-26184
Type: Notice
Date: 2021-12-03
Agency: Department of Health and Human Services
The U.S. Department of Health and Human Services (HHS) solicits written comments on three new objectives proposed to be added to Healthy People 2030 since its launch in August 2020; written comments from the public proposing additional new core, developmental, or research objectives to be included in Healthy People 2030; and evidence-based information regarding the relationship between voter participation and health status as a measure of civic engagement. Public comment informed the development of Healthy People 2030. HHS will provide opportunities for public input periodically throughout the decade to ensure Healthy People 2030 reflects current public health priorities and public input. The updated set of Healthy People 2030 objectives will be incorporated on www.health.gov/HealthyPeople2030. This updated set will reflect further review and deliberation by federal Healthy People topic area workgroups, the Federal Interagency Workgroup on Healthy People 2030, and other federal subject matter experts.
Request for Information; Health and Safety Requirements for Transplant Programs, Organ Procurement Organizations, and End-Stage Renal Disease Facilities
Document Number: 2021-26146
Type: Proposed Rule
Date: 2021-12-03
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This request for information solicits public comments on potential changes to the requirements that transplant programs, organ procurement organizations, and end-stage renal disease facilities must meet in order to participate in the Medicare and Medicaid programs. These providers and suppliers are integral to the transplant ecosystem in the United States and to the health of patients across the Nation. We are seeking public comment that will help to inform potential changes that would create system-wide improvements, which would further lead to improved organ donation, organ transplantation, quality of care in dialysis facilities, and improved access to dialysis services.
Laboratory Accreditation for Analyses of Foods
Document Number: 2021-25716
Type: Rule
Date: 2021-12-03
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, the Agency, or we) is amending its regulations to establish a program for the testing of food in certain circumstances by accredited laboratories, as required under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Establishing this program will help FDA improve the safety of the U.S. food supply and protect U.S. consumers by helping ensure that certain food testing of importance to public health is conducted subject to appropriate oversight and in accordance with appropriate model standards to produce reliable and valid test results.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.